GYNECOLOGICAL MALIGNANCIES
Clinical trials for GYNECOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new GYNECOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for GYNECOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for women with Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a new drug called BL-M07D1 for women with advanced gynecologic cancers that have returned or spread and express a protein called HER2. The trial aims to find the safest and most effective dose and see how well the drug shrinks tumors. It is for patients whos…
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Blood test may reveal if cancer treatment is working
Knowledge-focused Recruiting nowThis study aims to see if tracking changes in a common inflammation marker (CRP) in the blood can predict how well patients with advanced gynecologic cancers respond to immunotherapy. It will involve 120 women already scheduled to receive standard immunotherapy and chemotherapy. …
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC